Aurobindo Subsidiary Petitions Amoxycillin Import Complaint, DGTR Initiates Anti-Dumping Investigation

Ø Amoxycillin trihydrate is a common penicillin-class prescription antibiotic used to treat a wide variety of bacterial infections

[DGTR Initiation Notification SETU Case ID – AD/OI/060/2026 dated 24 September, 2026]

· Initiation: DGTR has initiated an anti-dumping investigation concerning imports of Amoxycillin Trihydrate originating in or exported from China PR.

· Applicant: The application was filed by Apitoria Pharma Private Limited, a step-down wholly owned subsidiary of Aurobindo Pharma Ltd.

· Product under Consideration (PUC): Amoxycillin Trihydrate, a broad-spectrum penicillin antibiotic used for various bacterial infections.

· Subject Country: China PR.

· HS Classification: The PUC is presently imported under HSN 2941 1030, under Chapter 29. Classification is indicative and not binding on the scope of the PUC.

· Unit of Measurement: Metric Tonnes (MT).

· PCN Methodology: No Product Control Number (PCN) methodology has been proposed by the applicant. Interested parties may submit comments on the PUC scope and propose PCNs within 15 days of circulation of the initiation intimation.

· Like Article: DGTR has prima facie considered the domestic product and imported product to be like articles, based on physical/chemical characteristics, manufacturing process, uses, specifications, pricing, distribution and tariff classification.

· Period of Investigation (POI): 1 April 2025 to 31 March 2026. Injury period covers 1 April 2022 to 31 March 2026.

· Domestic Industry: Apitoria Pharma accounts for more than 35% of Indian production. Together with supporting producer Centrient Pharmaceuticals India Pvt. Ltd., it accounts for more than 60% of total Indian domestic production. DGTR therefore considers the applicant eligible as the domestic industry.

· Alleged Dumping: The applicant alleged that imports from China PR are being dumped into India. DGTR's comparison of normal value and export price at ex-factory level prima facie indicates a dumping margin above de-minimis and significant.

· Normal Value: The applicant sought treatment of China PR as a non-market economy and proposed determination of normal value under Rule 7/8 of Annexure I. As third-country market-economy data was not reliably available, normal value was constructed using the applicant's cost of production, adjusted for SG&A and reasonable profit.

· Export Price: DGCI&S import data was used to ascertain the ex-factory export price, with adjustments for ocean freight, insurance, port expenses, commission, bank charges, credit cost and inland freight.

· Injury: The applicant provided prima facie evidence of injury, including an increase in import volumes from China and an adverse impact on the profitability parameters of the domestic industry.

· Causal Link: DGTR found prima facie evidence of dumping, injury to the domestic industry and a causal link between dumped imports and injury, justifying initiation of the investigation.

· Purpose of Investigation: The investigation will determine the existence, degree and effect of dumping and, if warranted, recommend an appropriate anti-dumping duty sufficient to remove injury to the domestic industry.

· Submission Platform: Interested parties must register and submit information through the SETU portal, under SETU Case ID: ADI01/060/2026.

· Response Deadline: Confidential and non-confidential versions of submissions are generally required within 37 days from circulation/transmission of the non-confidential application under Rule 6(4).

· PUC/PCN Comments: The 15-day period for comments on PUC/PCN methodology runs concurrently with the above response period.

· Important: No anti-dumping duty has been imposed at this stage. This is an initiation notification; DGTR will conduct the investigation before reaching final findings/recommendation. The notification specifically states that the investigation is to determine whether dumping, injury and the appropriate amount of duty exist.

Effect of this Notification: Imports of Amoxycillin Trihydrate from China PR under/including HSN 2941 1030 are now subject to a DGTR anti-dumping investigation. Importers, Chinese exporters/producers and other interested parties should monitor the investigation and comply with the prescribed SETU filing deadlines.